Efficacy of COVID‐19 vaccines: Several modes of expression should be presented in scientific publications-Reference-Cited by-同舟云学术

Efficacy of COVID‐19 vaccines: Several modes of expression should be presented in scientific publications

Published:2021-07-29 Issue:1 Volume:36 Page:218-220
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Montastruc Jean‐Louis¹^ORCID,Biron Pierre²,Sommet Agnès¹

Affiliation:

1. Service de Pharmacologie Médicale et Clinique, CIC INSERM 1436 Centre Hospitalier Universitaire‐Faculté de Médecine Toulouse France

2. Faculté de Médecine Université de Montréal Montréal Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12715

Reference12 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

4. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

5. Vaccines and Related Biological Products Advisory Committee Meeting.February 26 2021.FDA Briefing Document Janssen Ad26.COV2.S Vaccine for the Prevention of COVID‐19https://www.fda.gov/media/146217/download(accessed May 5 2021)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic;Expert Opinion on Drug Safety;2024-06-19

2. Effectiveness of the first and the second dose of COVID-19 vaccines in Serbia during the first three months of rollout;Srpski arhiv za celokupno lekarstvo;2024

3. Vestibular disorders following BNT162b2 mRNA COVID‐19 vaccination: A retrospective case series;Fundamental & Clinical Pharmacology;2023-07-20

4. Comparative mRNA booster effectiveness against death or hospitalization with COVID-19 pneumonia across at-risk US Veteran populations;Nature Communications;2023-05-23

5. How missing evidence-based medicine indicators can inform COVID-19 vaccine distribution policies: a scoping review and calculation of indicators from data in randomised controlled trials;BMJ Open;2022-12